Webinar series: The Analytical Landscape of Cannabis Testing Session 2: Pesticides by GC-MS/MS
Cannabis pesticide testing is challenging due to the variety of pesticides analyzed, low level detection expectations and the challenging matrix that cannabis and cannabis-infused products often present.
Challenges of Regulatory Oversight, Quality Testing, and Standardization within a Global Patchwork of Hemp Markets
In this webinar, Kim Ross, PhD, Chief Science Officer at Peak Compliance Labs will be discussing the establishment and standardization of consumer safety benchmarks for hemp-derived products, including an overview of current state-mandated testing for cannabis in the US and suitability of this framework for hemp quality control testing.
Webinar series: The Analytical Landscape of Cannabis Testing Session 1: Potency Testing
Legalization of medical and recreational cannabis and hemp has led to an expansion of potency testing needs.
Psychedelics and the Neurobiology of Fast-acting Antidepressants
Join Alex Kwan, PhD, Associate Professor at the Department of Psychiatry, Yale University, who will be presenting his lab's latest research into ketamine and psilocybin.
The Rapid and Accurate Analysis of Terpenes in a Commercial Laboratory Setting
Join Adam Floyd, Co-Founder of Cascade Laboratory Consulting and CSO of The Higher Commitment, who will be exploring the analysis of terpenes in a commercial laboratory setting and how it differs from the needs of a research laboratory.
Hemp – A wonder Crop with Countless Applications
The cultivation and production of hemp is a growing industry worldwide because of its countless commercial applications.
Essential Analytical Tools for a Premium Cannabis Extraction Facility
The cannabis oil market continues to grow at a rapid pace, as many operators are investigating new and improved vehicles for cannabis consumption.
Psychedelics in Psychiatry
Join Prof. Matthew Johnson, PhD, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine as he explores how psychedelics may be leveraged in the treatment of a variety of nominally distinct psychiatric disorders.
Cannabis Standardization: Product Quality Specification and Certification Programs Are Finally Here
Join David Vaillencourt, CEO, The GMP Collective and Darwin Millard, The Spock of Cannabis in this free webinar which will provide an update on cannabis standardization from ASTM and what the future has in store.
Product and Partnership Development: Why Both Matter for Your Cannabis Company
In this session, Cannacraft and Pall Corporation will share their experiences with new product development and how manufacturing equipment plays a role in the process.
